SCHEMBL4479941

SCHEMBL4479941

COc1cc(-c2cnc(N)c3c(-c4ccc(C(C)=O)cc4)csc23)cc(OC)c1OC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 6/20 0.76
FYN P06241 5/20 0.53
KDR P35968 6/20 0.48
AURKB Q96GD4 4/20 0.48
BTK Q06187 3/20 0.48
NEK2 P51955 1/20 0.47
TGFBR1 P36897 1/20 0.46
CHEK2 O96017 1/20 0.46
RPS6KA5 O75582 1/20 0.45
MAP4K4 O95819 1/20 0.45
ABL1 P00519 1/20 0.45
NTRK1 P04629 1/20 0.45
INSR P06213 1/20 0.45
LYN P07948 1/20 0.45
MET P08581 1/20 0.45
KIT P10721 1/20 0.45
FGFR1 P11362 1/20 0.45
SRC P12931 1/20 0.45
FER P16591 1/20 0.45
AXL P30530 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471359 0.86 EPHB4 (1.00) EPHB4FYNKDRAURKBBTK
SCHEMBL4467196 0.85 EPHB4 (1.00) EPHB4FYNKDRAURKBBTK
SCHEMBL4469106 0.80 EPHB4 (0.76) EPHB4FYNKDRTGFBR1CHEK2
SCHEMBL4475736 0.80 EPHB4 (1.00) EPHB4FYNKDRBTK
SCHEMBL4471724 0.80 EPHB4 (0.72) EPHB4FYNKDRAURKBTGFBR1
SCHEMBL4475148 0.80 EPHB4 (0.64) EPHB4FYNKDRAURKBBTK
SCHEMBL3529778 0.79 KDR (0.78) FYNKDRAURKBBTKNEK2
SCHEMBL4473618 0.79 EPHB4 (1.00) EPHB4FYNKDRTGFBR1
SCHEMBL4461250 0.78 EPHB4 (0.70) EPHB4FYNKDRAURKBBTK
SCHEMBL4464914 0.78 EPHB4 (0.69) EPHB4FYNTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US claimed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US claimed
JP-2006528685-A 2006-12-21 JP claimed
EP-1620094-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-02-01 EP claimed
WO-2004100947-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-11-25 WO claimed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182868-A1 Novel chemical compounds HRAS, VHL, TP53 EPHB4 2484/4885FYN 405/4885KDR 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.